Sulphydryl reactivity of the HLA-B27 epitope: accessibility of the free cysteine studied by flow cytometry.
Open Access
- 1 April 1992
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 51 (4) , 456-460
- https://doi.org/10.1136/ard.51.4.456
Abstract
HLA-B27 has an unpaired cysteine on or near its serologically defined spondylitis associated epitope, and it has been argued that its sulphydryl side chain may be chemically reactive. In a previous study it was shown that chemical treatment of HLA-B27 cells with the sulphydryl binding agent p-chloromercuriphenylsulphonic acid (pCMPSA) specifically reduced binding of antibodies to HLA-B27 by up to 80%, as measured in a cellular enzyme linked immunosorbent assay (CELISA). The effect of sulphydryl blockade on intact B27 cells was investigated using flow cytometry. Compared with the CELISA, inhibition required higher concentrations of pCMPSA, and the degree of inhibition produced by a greater than or equal to 30 microM solution of pCMPSA as measured by flow cytometry (median 28.9%) was significantly lower than that measured by CELISA (median 73.6%; p = 1.6 x 10(-6)). Analysis of unfixed, cell surface HLA-B27 by flow cytometry suggests that on most B27 molecules the unpaired sulphydryl site is not available. On the basis of this evidence for modification after translation, a new 'altered self' hypothesis is proposed for the part which HLA-B27 plays in inflammatory disease.Keywords
This publication has 20 references indexed in Scilit:
- Immunology, genetics, and animal models of the spondyloarthropathiesCurrent Opinion in Rheumatology, 1990
- Guilt by association: HLA-B27 and ankylosing spondylitisImmunology Today, 1990
- Direct binding of influenza peptides to class I HLA moleculesNature, 1989
- HLA-B27 and the causes of arthritis: does molecular biology help?Annals of the Rheumatic Diseases, 1987
- Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules.Annals of the Rheumatic Diseases, 1987
- Description of a mouse monoclonal anti-HLA-B27 antibody HLA-ABC-m3Human Immunology, 1983
- Structural Identity of Human Histocompatibility Leukocyte Antigen-B27 Molecules from Patients with Ankylosing Spondylitis and Normal IndividualsJournal of Clinical Investigation, 1982
- Monoclonal Antibody to HLA-A3Hybridoma, 1982
- A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17Human Immunology, 1980
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978